長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【2342】トランスジェニックグループ

【2342】トランスジェニックグループ
CRO。創薬用マウスの作製。
類似企業：


東証グロース
サー
＞
治験
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2025.03 2024/11/12 Q2予 12,500 ↓ -7.4% -7.4% -110 ↓ -131.4% -131.4% -180 ↓ -172.0% -172.0% -210 ↓ -310.0% -310.0%
2025.03 2024/08/09 Q1予 13,500 → 0.0% 0.0% 350 → 0.0% 0.0% 250 → 0.0% 0.0% 100 → 0.0% 0.0%
2025.03 2024/05/10 当初予 13,500 - - - 350 - - - 250 - - - 100 - - -
2024.03 2024/05/10 実 13,083 ↑ +0.3% +4.7% 89 ↓ -1.1% -70.3% 108 ↑ +13.7% -56.8% 4 ↓ -20.0% -97.3%
2024.03 2024/04/24 修正予 13,050 ↑ +0.4% +4.4% 90 ↑ +280.0% -70.0% 95 ↑ +235.7% -62.0% 5 ↑ +105.6% -96.7%
2024.03 2024/02/09 Q3予 13,000 ↑ +4.0% +4.0% -50 ↓ -116.7% -116.7% -70 ↓ -128.0% -128.0% -90 ↓ -160.0% -160.0%
2024.03 2023/11/10 Q2予 12,500 → 0.0% 0.0% 300 → 0.0% 0.0% 250 → 0.0% 0.0% 150 → 0.0% 0.0%
2024.03 2023/08/10 Q1予 12,500 → 0.0% 0.0% 300 → 0.0% 0.0% 250 → 0.0% 0.0% 150 → 0.0% 0.0%
2024.03 2023/05/12 当初予 12,500 - - - 300 - - - 250 - - - 150 - - -
2023.03 2023/05/12 実 11,429 ↓ -0.2% -0.6% -25 ↑ +16.7% -104.5% 199 ↓ -0.5% -60.2% -409 ↑ +9.1% -223.9%
2023.03 2023/04/26 修正予 11,450 ↓ -2.1% -0.4% -30 ↓ -114.3% -105.5% 200 ↓ -53.5% -60.0% -450 ↓ -336.8% -236.4%
2023.03 2023/02/10 Q3予 11,700 ↑ +1.7% +1.7% 210 ↓ -61.8% -61.8% 430 ↓ -14.0% -14.0% 190 ↓ -42.4% -42.4%
2023.03 2022/11/11 Q2予 11,500 → 0.0% 0.0% 550 → 0.0% 0.0% 500 → 0.0% 0.0% 330 → 0.0% 0.0%
2023.03 2022/08/12 Q1予 11,500 → 0.0% 0.0% 550 → 0.0% 0.0% 500 → 0.0% 0.0% 330 → 0.0% 0.0%
2023.03 2022/05/13 当初予 11,500 - - - 550 - - - 500 - - - 330 - - -
2022.03 2022/05/13 実 12,576 ↑ +0.6% +4.8% 1,837 ↑ +0.4% +53.1% 1,819 ↓ -0.1% +65.4% 1,876 ↓ -1.3% +212.7%
2022.03 2022/04/21 修正予 12,500 ↓ -1.6% +4.2% 1,830 ↓ -3.7% +52.5% 1,820 ↓ -1.6% +65.5% 1,900 ↓ -9.5% +216.7%
2022.03 2022/02/14 Q3予 12,700 ↓ -5.2% +5.8% 1,900 ↓ -9.5% +58.3% 1,850 ↓ -7.5% +68.2% 2,100 ↑ +75.0% +250.0%
2022.03 2021/11/12 Q2予 13,400 ↑ +3.1% +11.7% 2,100 ↑ +23.5% +75.0% 2,000 ↑ +25.0% +81.8% 1,200 ↑ +33.3% +100.0%
2022.03 2021/08/13 Q1予 13,000 → 0.0% +8.3% 1,700 → 0.0% +41.7% 1,600 → 0.0% +45.5% 900 → 0.0% +50.0%
2022.03 2021/07/13 修正予 13,000 ↑ +8.3% +8.3% 1,700 ↑ +41.7% +41.7% 1,600 ↑ +45.5% +45.5% 900 ↑ +50.0% +50.0%
2022.03 2021/05/14 当初予 12,000 - - - 1,200 - - - 1,100 - - - 600 - - -
2021.03 2021/05/14 実 11,046 ↑ +0.4% +5.2% 893 ↑ +0.3% +98.4% 891 ↑ +0.1% +122.8% 546 ↑ +1.1% +95.0%
2021.03 2021/04/30 修正予 11,000 ↓ -0.5% +4.8% 890 ↑ +11.3% +97.8% 890 ↑ +18.7% +122.5% 540 ↓ -6.1% +92.9%
2021.03 2021/02/12 Q3予 11,050 → 0.0% +5.2% 800 → 0.0% +77.8% 750 → 0.0% +87.5% 575 → 0.0% +105.4%
2021.03 2021/01/18 修正予 11,050 ↑ +5.2% +5.2% 800 ↑ +77.8% +77.8% 750 ↑ +87.5% +87.5% 575 ↑ +105.4% +105.4%
2021.03 2020/11/12 当初予 10,500 - - - 450 - - - 400 - - - 280 - - -
2020.03 2020/05/12 実 11,046 ↑ +2.3% +12.1% 173 ↑ +23.6% -50.6% 94 ↑ +34.3% -67.6% -440 ↑ +2.2% -314.6%
2020.03 2020/04/03 修正予 10,800 ↑ +2.9% +9.6% 140 ↓ -30.0% -60.0% 70 ↓ -50.0% -75.9% -450 ↓ -662.5% -319.5%
2020.03 2020/02/07 修正予 10,500 ↑ +6.6% +6.6% 200 ↓ -42.9% -42.9% 140 ↓ -51.7% -51.7% 80 ↓ -61.0% -61.0%
2020.03 2019/11/08 Q2予 9,850 → 0.0% 0.0% 350 → 0.0% 0.0% 290 → 0.0% 0.0% 205 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 9,850 → 0.0% 0.0% 350 → 0.0% 0.0% 290 → 0.0% 0.0% 205 → 0.0% 0.0%
2020.03 2019/05/10 当初予 9,850 - - - 350 - - - 290 - - - 205 - - -
2019.03 2019/05/10 実 8,674 ↓ -0.0% +2.0% 270 → 0.0% -10.0% 256 ↑ +0.4% +2.4% 202 ↑ +1.0% +34.7%
2019.03 2019/04/24 修正予 8,675 ↑ +2.1% +2.1% 270 ↓ -10.0% -10.0% 255 ↑ +2.0% +2.0% 200 ↑ +33.3% +33.3%
2019.03 2019/02/08 Q3予 8,500 → 0.0% 0.0% 300 → 0.0% 0.0% 250 → 0.0% 0.0% 150 → 0.0% 0.0%
2019.03 2018/11/09 Q2予 8,500 → 0.0% 0.0% 300 → 0.0% 0.0% 250 → 0.0% 0.0% 150 → 0.0% 0.0%
2019.03 2018/08/10 Q1予 8,500 → 0.0% 0.0% 300 - - - 250 → 0.0% 0.0% 150 → 0.0% 0.0%
2019.03 2018/05/11 当初予 8,500 - - - - - - - 250 - - - 150 - - -
2018.03 2018/05/11 実 - - - - - - - - - - - - - - - -
2018.03 2018/04/25 修正予 3,600 ↑ +49.4% +49.4% - - - - 14 ↓ -91.8% -91.8% 20 ↓ -81.8% -81.8%
2018.03 2018/02/02 Q3予 2,410 → 0.0% 0.0% 200 → 0.0% 0.0% 170 → 0.0% 0.0% 110 → 0.0% 0.0%
2018.03 2017/11/10 Q2予 2,410 → 0.0% 0.0% 200 → 0.0% 0.0% 170 → 0.0% 0.0% 110 → 0.0% 0.0%
2018.03 2017/08/03 Q1予 2,410 → 0.0% 0.0% 200 → 0.0% 0.0% 170 → 0.0% 0.0% 110 → 0.0% 0.0%
2018.03 2017/05/12 当初予 2,410 - - - 200 - - - 170 - - - 110 - - -
2017.03 2017/05/12 実 2,302 → 0.0% -9.7% 153 → 0.0% +2.0% 88 → 0.0% -20.0% 80 → 0.0% +23.1%
2017.03 2017/04/26 修正予 2,302 ↓ -9.7% -9.7% 153 ↑ +2.0% +2.0% 88 ↓ -20.0% -20.0% 80 ↑ +23.1% +23.1%
2017.03 2017/02/03 Q3予 2,550 → 0.0% 0.0% 150 → 0.0% 0.0% 110 → 0.0% 0.0% 65 → 0.0% 0.0%
2017.03 2016/11/04 Q2予 2,550 → 0.0% 0.0% 150 → 0.0% 0.0% 110 → 0.0% 0.0% 65 → 0.0% 0.0%
2017.03 2016/08/04 Q1予 2,550 → 0.0% 0.0% 150 → 0.0% 0.0% 110 → 0.0% 0.0% 65 → 0.0% 0.0%
2017.03 2016/05/12 当初予 2,550 - - - 150 - - - 110 - - - 65 - - -
2016.03 2016/05/12 実 2,290 → 0.0% +6.5% 50 → 0.0% +25.0% 18 → 0.0% -48.6% 14 → 0.0% -22.2%
2016.03 2016/04/20 修正予 2,290 ↑ +6.5% +6.5% 50 ↑ +25.0% +25.0% 18 ↓ -48.6% -48.6% 14 ↓ -22.2% -22.2%
2016.03 2016/02/04 Q3予 2,150 → 0.0% 0.0% 40 → 0.0% 0.0% 35 → 0.0% 0.0% 18 → 0.0% 0.0%
2016.03 2015/11/05 Q2予 2,150 → 0.0% 0.0% 40 → 0.0% 0.0% 35 → 0.0% 0.0% 18 → 0.0% 0.0%
2016.03 2015/08/06 Q1予 2,150 → 0.0% 0.0% 40 → 0.0% 0.0% 35 → 0.0% 0.0% 18 → 0.0% 0.0%
2016.03 2015/05/14 当初予 2,150 - - - 40 - - - 35 - - - 18 - - -
2015.03 2015/05/14 実 1,958 → 0.0% -2.1% 23 → 0.0% +15.0% 9 → 0.0% -55.0% 17 ↓ -5.6% +13.3%
2015.03 2015/04/22 修正予 1,958 ↓ -2.1% -2.1% 23 ↑ +15.0% +15.0% 9 ↓ -55.0% -55.0% 18 ↑ +20.0% +20.0%
2015.03 2015/02/05 Q3予 2,000 → 0.0% 0.0% 20 → 0.0% 0.0% 20 → 0.0% 0.0% 15 → 0.0% 0.0%
2015.03 2014/11/06 Q2予 2,000 → 0.0% 0.0% 20 → 0.0% 0.0% 20 → 0.0% 0.0% 15 → 0.0% 0.0%
2015.03 2014/08/07 Q1予 2,000 → 0.0% 0.0% - - - - 20 → 0.0% 0.0% 15 → 0.0% 0.0%
2015.03 2014/05/08 当初予 2,000 - - - 20 - - - 20 - - - 15 - - -
2014.03 2014/05/08 実 1,617 ↓ -0.8% -0.8% -85 ↑ +5.6% +5.6% -122 ↑ +6.2% +6.2% -113 ↑ +5.8% +5.8%
2014.03 2014/03/20 当初予 1,630 - - - -90 - - - -130 - - - -120 - - -
シェア ツイート
ページトップへ戻る